Geneyx Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 13

Geneyx General Information

Description

Developer of a business-to-business software-as-a-service multi-omics bioinformatics platform designed for precision medicine and drug discovery. The company offers bioinformatics capabilities that generate high-accuracy insights from multi-omics data, enabling healthcare and life sciences organizations to support precision medicine applications and early-stage drug discovery.

Contact Information

Website
www.geneyx.com
Formerly Known As
TGex
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11/B Galgaley-Haplada Street
  • Herzliya 4672211
  • Israel
+972
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Corporate Office
  • 11/B Galgaley-Haplada Street
  • Herzliya 4672211
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Geneyx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator 21-Sep-2024 Completed Generating Revenue
8. Accelerator/Incubator Completed Generating Revenue
7. Seed Round 01-Jul-2022 Completed Generating Revenue
6. Seed Round 01-Sep-2021 Completed Generating Revenue
5. Early Stage VC Cancelled Generating Revenue
4. Seed Round 14-Apr-2020 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
2. Seed Round 01-May-2019 $83.4K $165K Completed Generating Revenue
1. Seed Round 01-Sep-2018 $81.9K $81.9K Completed Startup
To view Geneyx’s complete valuation and funding history, request access »

Geneyx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 1
Seed 2
Seed 1 211,890 $4.27 $4.27 1x $4.27 11.11%
To view Geneyx’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Geneyx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a business-to-business software-as-a-service multi-omics bioinformatics platform designed for precision med
Other Healthcare Technology Systems
Herzliya, Israel
20 As of 2026

Montpellier, France
 

Oakland, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Geneyx Competitors (4)

One of Geneyx’s 4 competitors is SeqOne, a Venture Capital-Backed company based in Montpellier, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SeqOne Venture Capital-Backed Montpellier, France
Fabric Genomics Formerly VC-backed Oakland, CA
Genoox Formerly PE-Backed Palo Alto, CA
Congenica Formerly VC-backed Cambridge, United Kingdom
To view Geneyx’s complete competitors history, request access »

Geneyx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Geneyx Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Google Accelerator Accelerator/Incubator
Digilife Venture Capital Minority
Accenture Ventures Corporate Venture Capital Minority
Apple Core Holdings Venture Capital Minority
Capria Ventures Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Geneyx Acquisitions (1)

Geneyx’s most recent deal was a Merger/Acquisition with Toldot Genetics for . The deal was made on 12-Oct-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Toldot Genetics 12-Oct-2020 Merger/Acquisition Biotechnology
To view Geneyx’s complete acquisitions history, request access »

Geneyx FAQs

  • When was Geneyx founded?

    Geneyx was founded in 2018.

  • Where is Geneyx headquartered?

    Geneyx is headquartered in Herzliya, Israel.

  • What is the size of Geneyx?

    Geneyx has 20 total employees.

  • What industry is Geneyx in?

    Geneyx’s primary industry is Other Healthcare Technology Systems.

  • Is Geneyx a private or public company?

    Geneyx is a Private company.

  • What is Geneyx’s current revenue?

    The current revenue for Geneyx is .

  • How much funding has Geneyx raised over time?

    Geneyx has raised $11.6M.

  • Who are Geneyx’s investors?

    Google Accelerator, Digilife, Accenture Ventures, Apple Core Holdings, and Capria Ventures are 5 of 13 investors who have invested in Geneyx.

  • Who are Geneyx’s competitors?

    SeqOne, Fabric Genomics, Genoox, and Congenica are competitors of Geneyx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process